Developing story β details emerging. Check the source link for the latest updates.
Source: [Seeking Alpha](https://seekingalpha.com/article/4938319-toyo-co-ltd-toyo-q2-2026-earnings-call-transcript?source=feed_all_articles)
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Bloomberg's Randall Williams joins Dani Burger on "Bloomberg Deals. " Billionaire CEO of Guggenheim, Mark Walter, has explored selling his stake in Chelsea FC to Clearlake Capital, the majority owner of the London-based football club. This comes just after Walter's record-breaking sale of the Lo...
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.